Currently raising capital to fund a pivotal 150 patient study planned for 2nd quarter of 2016. Submitting applications to begin developing strategic partnerships with leading pharma companies.
Milestones and catalysts
Intellectual Property: Patents issued in 2002, 2004, 2007
Regulatory: Blue Letters releasing trials under EMA rules issued March 2016. Expecting to File US IND based on these studies in the 2nd quarter of 2017
Must raise capital to complete trials and to fund their development efforts.